市場調查報告書

全球生命科學試劑市場:成長,趨勢,及預測

Life Science Reagents Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921997
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
全球生命科學試劑市場:成長,趨勢,及預測 Life Science Reagents Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 114 Pages
簡介

本報告提供全球生命科學試劑市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,產品類型·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 感染疾病的高盛行率
    • 生命科學·生物科技領域技術的進步
  • 市場阻礙因素
    • 試劑的高成本
    • 嚴格的法律規範
  • 波特的五力分析

第5章 市場區隔

  • 各產品類型
    • 細胞·組織培養試劑
    • 色譜試劑
    • 臨床化學試劑
    • 免疫測量試劑
    • 分子診斷試劑
    • 微生物學試劑
    • 其他
  • 各終端用戶
    • 醫院·診斷研究所
    • 學術研究機關
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific, Inc
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • BioMerieux SA
    • Merck KGaA
    • Danaher Corporation
    • Siemens Healthineers
    • DiaSorin SpA
    • Sysmex Corporation

第7章 市場機會及今後趨勢

目錄
Product Code: 67565

Market Overview

The life science reagents market is expected to grow with a CAGR of 7.7%, during the forecast period. A reagent is a compound or mixture which is added to a system to occur a chemical reaction or a test if a reaction occurs. Reagents may be compounds or mixtures in organic chemicals, most of the reagents are small organic molecules or inorganic compounds. Life science reagents play a key role in the cell-based products, manufacturing, and testing of pharmaceutical drug products and several other healthcare-related solutions. In the year 2015, the United States reported 62 Zika virus infection cases, then over 5,000 cases in 2016 among Florida state with the highest number of reported Zika virus cases with 1,115. An increase in the prevalence of chronic and infectious diseases, rise in geriatric population and technological advancements in the field of life sciences and biotechnology are the key driving factors in the life science reagents market.

Scope of the Report

As per the scope of the report, a reagent is a compound or mixture which is added to a system to occur a chemical reaction or a test if a reaction occurs. Life Science Reagents Market is segmented by Product Type, By End User and Geography.

Key Market Trends

Hospitals and Diagnostic Laboratories Segment is Expected to Hold a Major Market Share in the Life Science Reagents Market

  • Globally, infectious diseases are a leading cause of death, particularly in low-income countries, especially in young children. According to the World Health Organization (WHO), lower respiratory infections resulted in 3.0 million deaths, diarrheal diseases resulted in 1.4 million deaths and tuberculosis resulted in 1.3 million deaths.
  • From 2017-2018, hospitals and diagnostic laboratories segment hold a major market share and is expected to grow significantly over the forecast period.
  • Increasing the prevalence of chronic and viral infectious diseases requires efficient testing in medical specialties and diagnostic care centers.
  • In diagnostic laboratories and hospitals, the adoption of life science reagents has increased which is likely in the foreseeable future to maintain the pace of the market for life science reagents.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global life science reagents market due to a rise in the geriatric population, increasing prevalence and incidence of infectious diseases in this region. In 2018, North America holds a major market share for life science reagents and this trend will remain in the forecast period as well. Moreover, an increase in research and development activities and the presence of favorable healthcare infrastructure are fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The life science reagents market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the major market players are Hoffmann-La Roche, Thermo Fisher Scientific, Inc, Becton, Dickinson, and Company, Abbott, BioMerieux SA, Merck KGaA, Danaher Corporation, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Prevalence of Infectious Diseases
    • 4.2.2 Technological Advancements in the Field of Life Sciences and Biotechnology
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Reagents
    • 4.3.2 Stringent Regulatory Framework
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Poduct Type
    • 5.1.1 Cell and Tissue Culture Reagents
    • 5.1.2 Chromatography Reagents
    • 5.1.3 Clinical Chemistry Reagents
    • 5.1.4 Immunoassay Reagents
    • 5.1.5 Molecular Diagnostic Reagents
    • 5.1.6 Microbiology Reagents
    • 5.1.7 Others
  • 5.2 By End User
    • 5.2.1 Hospitals and Diagnostic Laboratories
    • 5.2.2 Academic and Research Institutes
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 F. Hoffmann-La Roche Ltd
    • 6.1.2 Thermo Fisher Scientific, Inc
    • 6.1.3 Becton, Dickinson and Company
    • 6.1.4 Abbott Laboratories
    • 6.1.5 BioMerieux SA
    • 6.1.6 Merck KGaA
    • 6.1.7 Danaher Corporation
    • 6.1.8 Siemens Healthineers
    • 6.1.9 DiaSorin S.p.A
    • 6.1.10 Sysmex Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS